HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 81 filers reported holding HARPOON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $759 | -51.3% | 1,070 | -49.0% | 0.00% | – |
| Q1 2023 | $1,560 | – | 2,098 | +37.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 1,531 | +124.5% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 682 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 682 | -24.1% | 0.00% | – |
| Q1 2022 | $3,000 | -40.0% | 899 | +40.2% | 0.00% | – |
| Q4 2021 | $5,000 | -61.5% | 641 | -14.5% | 0.00% | – |
| Q3 2020 | $13,000 | +8.3% | 750 | 0.0% | 0.00% | – |
| Q2 2020 | $12,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $66,038,000 | 15.37% |
| MPM ASSET MANAGEMENT LLC | 3,238,306 | $67,745,000 | 13.09% |
| MPM BioImpact LLC | 3,898,422 | $81,555,000 | 10.25% |
| Aquilo Capital Management, LLC | 1,554,199 | $32,514,000 | 5.88% |
| Altium Capital Management LP | 199,607 | $4,176,000 | 1.16% |
| SECTORAL ASSET MANAGEMENT INC | 631,050 | $13,202,000 | 1.00% |
| Avidity Partners Management LP | 1,408,000 | $29,455,000 | 0.81% |
| DAFNA Capital Management LLC | 126,663 | $2,650,000 | 0.63% |
| Logos Global Management LP | 300,000 | $6,276,000 | 0.61% |
| Orbimed Advisors | 2,285,704 | $47,817,000 | 0.45% |